Next Article in Journal
Synthesis by Ring-Closing Metathesis and Cytotoxic Evaluation of Novel Thienylmacrolactones
Previous Article in Journal
Iontophoresis: A Potential Emergence of a Transdermal Drug Delivery System
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 81
Issue 3
10.3797/scipharm.1302-13
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Randomized, Crossover, Single-Dose Bioequivalence Study of Two Extended-Release Tablets of Donepezil 23 mg in Healthy Human Volunteers under Fasting and Fed States

by
Chaitanya GADIKO
,
Sudhakar KOUNDINYA TIPPABHOTLA
*,
Satyanarayana THOTA
,
Ramakrishna BATTULA
,
Sohel Md. KHAN
and
Venkateswarlu VOBALABOINA
Clinical Pharmacology and Pharmacokinetics, Integrated Product Development, Dr. Reddy’s Laboratories Ltd., Hyderabad-500090, India
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2013, 81(3), 777-792; https://doi.org/10.3797/scipharm.1302-13
Submission received: 25 February 2013 / Accepted: 25 April 2013 / Published: 25 April 2013
Versions Notes

Abstract

To assess the bioequivalence of two extended-release tablets of donepezil 23 mg, open label, randomized, single-dose, two-sequence, two-period cross-over studies under fasting (n=74) and fed (n=94) conditions in healthy adult human volunteers were conducted. Subjects were randomized to either of the two treatment arms (test or reference) separated by a washout period of 28 days. Blood samples were collected up to 72 h post-dose and plasma samples were analyzed for donepezil using a validated LC-MS/MS method. Pharmaco-kinetic parameters were derived using a non-compartmental approach. Bioequivalence was evaluated in 69 subjects in the fasting study, and 71 subjects in the fed study. In the fasting study, the 90% CI of Cmax and AUC0-72 were 82.50–90.10 and 92.38–98.60, respectively. Corresponding values in the fed study were 91.82–98.05 and 97.27–100.27. Based on the results, the test product (donepezil) met the US regulatory criteria of bioequivalence relative to the reference product (Aricept®) under both fasting and fed conditions.
Keywords: Bioequivalence; Donepezil; Pharmacokinetic; Non-compartmental Bioequivalence; Donepezil; Pharmacokinetic; Non-compartmental

Share and Cite

MDPI and ACS Style

GADIKO, C.; TIPPABHOTLA, S.K.; THOTA, S.; BATTULA, R.; KHAN, S.M.; VOBALABOINA, V. A Randomized, Crossover, Single-Dose Bioequivalence Study of Two Extended-Release Tablets of Donepezil 23 mg in Healthy Human Volunteers under Fasting and Fed States. Sci. Pharm. 2013, 81, 777-792. https://doi.org/10.3797/scipharm.1302-13

AMA Style

GADIKO C, TIPPABHOTLA SK, THOTA S, BATTULA R, KHAN SM, VOBALABOINA V. A Randomized, Crossover, Single-Dose Bioequivalence Study of Two Extended-Release Tablets of Donepezil 23 mg in Healthy Human Volunteers under Fasting and Fed States. Scientia Pharmaceutica. 2013; 81(3):777-792. https://doi.org/10.3797/scipharm.1302-13

Chicago/Turabian Style

GADIKO, Chaitanya, Sudhakar KOUNDINYA TIPPABHOTLA, Satyanarayana THOTA, Ramakrishna BATTULA, Sohel Md. KHAN, and Venkateswarlu VOBALABOINA. 2013. "A Randomized, Crossover, Single-Dose Bioequivalence Study of Two Extended-Release Tablets of Donepezil 23 mg in Healthy Human Volunteers under Fasting and Fed States" Scientia Pharmaceutica 81, no. 3: 777-792. https://doi.org/10.3797/scipharm.1302-13

APA Style

GADIKO, C., TIPPABHOTLA, S. K., THOTA, S., BATTULA, R., KHAN, S. M., & VOBALABOINA, V. (2013). A Randomized, Crossover, Single-Dose Bioequivalence Study of Two Extended-Release Tablets of Donepezil 23 mg in Healthy Human Volunteers under Fasting and Fed States. Scientia Pharmaceutica, 81(3), 777-792. https://doi.org/10.3797/scipharm.1302-13

Article Metrics

Back to TopTop